微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 75.5% | -1.78% | -1.41% | 15/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 76.57% | -0.68% | 0.07% | 14/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 76.52% | 1.03% | 0.08% | 16/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 76.45% | 1.69% | -0.53% | 11/129 | 53.83% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 76.86% | 1.66% | -0.31% | 13/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 77.1% | 1.45% | 1.8% | 13/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 75.73% | -2.68% | 0.74% | 15/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 75.18% | -3.68% | -0.56% | 16/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 75.61% | -4.49% | -0.51% | 16/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 75.99% | -4.53% | -2.34% | 16/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 77.82% | -2.81% | -0.3% | 15/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 78.05% | -1.33% | -1.4% | 12/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 79.16% | 0.06% | -0.56% | 12/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 79.6% | 0.16% | -0.58% | 13/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 80.07% | 1.09% | 1.22% | 13/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 79.1% | -0.31% | -0.01% | 18/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 79.11% | -0.09% | -0.46% | 18/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 79.47% | 0.05% | 0.35% | 20/129 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 79.2% | 2% | -0.18% | 14/129 | 58.33% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 79.35% | 0.67% | 0.21% | 20/129 | 56.37% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 79.18% | 2% | -0.32% | 10/129 | 55.22% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 79.43% | 2% | 0.79% | 13/129 | 57.37% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 78.81% | 2% | 2% | 19/129 | 55.53% | 正海生物 | 93.85% | 行业排名> |